Skip to content
Medical Health Aged Care

Wage case recognises historic undervalued work of aged care nurses

Australian Nursing and Midwifery Federation (ANMF) 2 mins read

The Australian Nursing and Midwifery Federation (ANMF) has welcomed the Fair Work Commission’s (FWC) further recognition that the work of aged care workers has been historically undervalued in its Stage 3 decision for the aged care industry work value case announced today. 

The FWC has concluded that, for ‘work value reasons’, award rates for direct care employees should be increased substantially beyond the 15% increase determined in Stage 1. 

Federal Secretary Annie Butler said: “ANMF members will be pleased with this outcome, with some set to receive up to 28% increases on award rates (inclusive of the interim increase).

“While the FWC had deferred further pay rises for registered and enrolled nurses in the aged care sector for consideration in a separate application made by the ANMF for all employees covered by the Nurses Award, we are pleased that the FWC recognised that the ‘federal award system has failed to set minimum award rates of pay which properly recognise the addition to work value affected by the transformation of nursing into a profession’.

“We are also very pleased that the FWC is proposing a benchmark which will seek to address this historical, gender based undervaluation.

“ANMF witnesses including our members, union officials and academic experts, all gave evidence that the work performed in aged care has changed dramatically over the last two decades. Our evidence that the work has become more complex due to the higher needs and greater acuity of aged care residents and people receiving care at home was accepted. The FWC also agrees that the impact of COVID on delivery of care has brought about permanent change to the way work is performed.

 

“We look forward to progressing ou second Application so we can achieve the best outcomes for our members across the nursing workforce,” Ms Butler said.

 

 

More from this category

  • Medical Health Aged Care
  • 27/12/2024
  • 17:11
Takeda Pharmaceutical Company Limited

Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is the First and Only Facilitated Subcutaneous Immunoglobulin (fSCIG) Approved in Japan for Agammaglobulinemia…

  • Contains:
  • Medical Health Aged Care
  • 23/12/2024
  • 22:11
BeiGene, Ltd.

BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference

SAN MATEO, Calif.–BUSINESS WIRE– BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne…

  • Contains:
  • Medical Health Aged Care
  • 23/12/2024
  • 12:57
Royal Australian College of GPs

RACGP: Look after your mental health this holiday season

The Royal Australian College of GPs (RACGP) has urged Australians to look after themselves and their loved ones this holiday season. College President, Dr Michael Wright, said that reaching out and helping others can make all the difference. “The holiday season can be a challenging time for many Australians,” he said. “Many of us can have family and relationship pressures, financial pressures may become more obvious, and isolation and loneliness can be at their worst this time of year too. So, during this festive season please try to look after yourself and the people in your life. It can be…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.